3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.
A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)
The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.
Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
A genus of toxic herbaceous Eurasian plants of the Plantaginaceae which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.
C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.
Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.

Na(+) transport, and the E(1)P-E(2)P conformational transition of the Na(+)/K(+)-ATPase. (1/25)

We have used admittance analysis together with the black lipid membrane technique to analyze electrogenic reactions within the Na(+) branch of the reaction cycle of the Na(+)/K(+)-ATPase. ATP release by flash photolysis of caged ATP induced changes in the admittance of the compound membrane system that are associated with partial reactions of the Na(+)/K(+)-ATPase. Frequency spectra and the Na(+) dependence of the capacitive signal are consistent with an electrogenic or electroneutral E(1)P <--> E(2)P conformational transition which is rate limiting for a faster electrogenic Na(+) dissociation reaction. We determine the relaxation rate of the rate-limiting reaction and the equilibrium constants for both reactions at pH 6.2-8.5. The relaxation rate has a maximum value at pH 7.4 (approximately 320 s(-1)), which drops to acidic (approximately 190 s(-1)) and basic (approximately 110 s(-1)) pH. The E(1)P <--> E(2)P equilibrium is approximately at a midpoint position at pH 6.2 (equilibrium constant approximately 0.8) but moves more to the E(1)P side at basic pH 8.5 (equilibrium constant approximately 0.4). The Na(+) affinity at the extracellular binding site decreases from approximately 900 mM at pH 6.2 to approximately 200 mM at pH 8.5. The results suggest that during Na(+) transport the free energy supplied by the hydrolysis of ATP is mainly used for the generation of a low-affinity extracellular Na(+) discharge site. Ionic strength and lyotropic anions both decrease the relaxation rate. However, while ionic strength does not change the position of the conformational equilibrium E(1)P <--> E(2)P, lyotropic anions shift it to E(1)P.  (+info)

The current produced by the E779A mutant rat Na(+)/K(+) pump alpha1-subunit expressed in HEK 293 cells. (2/25)

The current (I(p)) generated by the wild-type or the glutamate (E) 779 alanine (A) mutant of the rat Na(+)/K(+) pump alpha1-subunit expressed in HEK 293 cells was studied at 35 degrees C by means of whole-cell recording in Na(+)-free and Na(+)-containing solution. Glutamate 779 is located in the fifth transmembrane domain of the alpha-subunit of the Na(+)/K(+)-ATPase. Compared with the wild-type, the E779A mutant exhibited an apparent K(+)(o)-affinity decreased by a factor of 3-4 both in Na(+)-free and in Na(+)-containing media. The competition of Na(+)(o) and K(+)(o) for cation binding sites of the pump remained unchanged. Similarly, in Na(+)-free solution the shape of the I(p)-V curves for various external K(+)-concentrations ([K(+)](o)) was essentially the same. However, in Na(+)-containing solutions the shape of I(p)-V curves from cells expressing the mutant of the rat alpha1-subunit clearly differed from the shape observed in cells expressing the wild-type, but voltage dependence of the pump current persisted. A prominent Na(+)(o)-activated, electrogenic Na(+)-transport mediated by the pump, displaying little voltage dependence in the potential range tested (-80 to +60 mV), was present in the cells expressing the E779A mutant pump. The data suggest that exchanging E779 for A in the rat Na(+)/K(+) pump alpha1-subunit causes a modest decrease in the apparent K(+)(o) affinity and a profound, Na(+)(o)-dependent alteration in the electrogenicity of the mutant pump expressed in HEK 293 cells.  (+info)

Voltage dependence of the apparent affinity for external Na(+) of the backward-running sodium pump. (3/25)

The steady-state voltage and [Na(+)](o) dependence of the electrogenic sodium pump was investigated in voltage-clamped internally dialyzed giant axons of the squid, Loligo pealei, under conditions that promote the backward-running mode (K(+)-free seawater; ATP- and Na(+)-free internal solution containing ADP and orthophosphate). The ratio of pump-mediated (42)K(+) efflux to reverse pump current, I(pump) (both defined by sensitivity to dihydrodigitoxigenin, H(2)DTG), scaled by Faraday's constant, was -1.5 +/- 0.4 (n = 5; expected ratio for 2 K(+)/3 Na(+) stoichiometry is -2.0). Steady-state reverse pump current-voltage (I(pump)-V) relationships were obtained either from the shifts in holding current after repeated exposures of an axon clamped at various V(m) to H(2)DTG or from the difference between membrane I-V relationships obtained by imposing V(m) staircases in the presence or absence of H(2)DTG. With the second method, we also investigated the influence of [Na(+)](o) (up to 800 mM, for which hypertonic solutions were used) on the steady-state reverse I(pump)-V relationship. The reverse I(pump)-V relationship is sigmoid, I(pump) saturating at large negative V(m), and each doubling of [Na(+)](o) causes a fixed (29 mV) rightward parallel shift along the voltage axis of this Boltzmann partition function (apparent valence z = 0.80). These characteristics mirror those of steady-state (22)Na(+) efflux during electroneutral Na(+)/Na(+) exchange, and follow without additional postulates from the same simple high field access channel model (Gadsby, D.C., R.F. Rakowski, and P. De Weer, 1993. Science. 260:100-103). This model predicts valence z = nlambda, where n (1.33 +/- 0.05) is the Hill coefficient of Na binding, and lambda (0.61 +/- 0.03) is the fraction of the membrane electric field traversed by Na ions reaching their binding site. More elaborate alternative models can accommodate all the steady-state features of the reverse pumping and electroneutral Na(+)/Na(+) exchange modes only with additional assumptions that render them less likely.  (+info)

The uptake and subcellular distribution of radio-labelled metabolites of digitoxin in the guinea-pig isolated perfused heart. (4/25)

1 Comparisons were made of the uptake and inotropic effects of concentrations of 0.1 muM of digitoxin and its cleavage products digitoxigenin-bis-digitoxoside, digitoxigenin-mono-digitoxoside and digitoxigenin in the isolated perfused hearts of guinea-pigs. 2 Digitoxin produced the greatest inotropic responses in this series, while the sequence of cleavage products produced progressively smaller responses. 3 The uptake of digitoxin was significantly higher than that of the three metabolites, and the uptake of metabolites became progressively less with cleavage. The highest binding in each case was found in the microsomal fraction. 4 The uptake of all four digitaloids was reduced when the potassium in the perfusion medium was increased.  (+info)

Increase in dissociation rate constants of cardiotonic steroid-brain (Na+ + K+)-ATPase complexes by reduction of the unsaturated lactone. (5/25)

Several cardiotonic steroids have been modified by reduction of the unsaturated lactone and their interactions with the sodium- and potassium-activated ATPase ((Na+ + K+)-ATPase) have been investigated. Reduction of the unsaturated lactone results in a decrease in binding affinity due primarily to an increase in the dissociation rate constant concomitant with a decrease in the activation free energy of dissociation. This decrease in activation free energy is about 2 to 4 kcal, which is approximately equal to the energy of one hydrogen bond. It is suggested that the increase in dissociation rate due to reduction of the unsaturated lactone may make possible the use of these compounds as affinity ligands for purification of the (Na+ + K+)-ATPase or an ouabain-binding fragment.  (+info)

Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. (6/25)

We have recently demonstrated that bufalin is a new potent inducer of the differentiation of human myeloid leukemia cells. The present work was carried out to examine further the effect of bufalin on the growth and characteristics of human leukemia-derived cell lines U937, ML1, and HL60. At concentrations of 5-10 nM, bufalin decreased the growth of ML1 cells preferentially at the G2 phase and U937 cells at the S and G2 phases of the cell cycle. Bufalin, under these conditions, induced the differentiation of U937, ML1, and HL60 cells to monocyte/macrophage-like cells by measuring the expression of various differentiation markers, as assessed by morphology and histochemistry, and ability to phagocytose latex particles, to reduce nitroblue tetrazolium, and to develop Fc receptors. U937 and ML1 cells started to differentiate at 4 and 6 h, respectively, after treatment with 10 nM bufalin and showed maximum differentiation 72 h later. At present, a mechanism for the bufalin-mediated induction of the differentiation of these human leukemia cells remains to be determined. The combination of bufalin with all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D3, 4'-demethylepipodophyllotoxin ethylidene-beta-D-glucoside (VP16), or human gamma-interferon synergistically induced the differentiation of HL60 and U937 cells. A similar effect on ML1 cells was observed with the combination of bufalin with VP16 or human rTNF-alpha. These results suggest that bufalin in combination with VP16, all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D3, rTNF-alpha, or gamma-interferon may be very useful in the differentiation of human leukemia.  (+info)

A stereoselective synthesis of digitoxin and digitoxigen mono- and bisdigitoxoside from digitoxigenin via a palladium-catalyzed glycosylation. (7/25)

A convergent and stereocontrolled route to trisaccharide natural product digitoxin has been developed. The route is amenable to the preparation of both the digitoxigen mono- and bisdigitoxoside. This route featured the iterative application of the palladium-catalyzed glycosylation reaction, reductive 1,3-transposition, diastereoselective dihydroxylation, and regioselective protection. The natural product digitoxin was fashioned in 15 steps starting from digitoxigenin 2 and pyranone 8a or 18 steps from achiral acylfuran.  (+info)

The asymmetric syntheses of methyl D-digitoxoside, L-oleandrose and L-cymarose from methyl sorbate, an achiral precursor. (8/25)

The addition of 4 eq of chloral to osmundalactone (4S,5R)-4 gave quantitative formation of the hemiacetal derivative (4S,5R)-8, which was treated with methane sulfonic acid to afford the intramolecular Micheal addition product (+)-(3S,4S,5R)-9 possessing a 3,4-cis-dihydroxy-delta-lactone in 78% overall yield from (4S,5R)-4. The obtained (+)-(3S,4S,5R)-9 was subsequently converted to methyl D-digitoxoside (pyranoside) (12) in 13% overall yield and methyl D-digitoxoside (furanoside) (12) in 20% overall yield. The reaction of benzyl-osmundalactone (4R,5S)-3 and MeOH in the presence of Amberlyst A-26 as a basic catalyst gave 3,4-trans-delta-lactone (-)-(3S,4R,5S)-20 in 28% yield and 3,4-cis-delta-lactone (-)-(3R,4R,5S)-21 in 45% yield. Dibal-H reduction of (-)-(3S,4R,5S)-20 followed by catalytic hydrogenation gave L-oleandrose (6) in 86% overall yield, while Dibal-H reduction of (-)-(3R,4R,5S)-21 followed by catalytic hydrogenation provided L-cymarose (7) in 85% overall yield.  (+info)

Digitoxigenin is a steroidal compound that is derived from digitalis plants, such as Digitalis lanata and Digitalis purpurea. It is a genin, which means it is a type of cardiac glycoside that does not contain a sugar molecule. Digitoxigenin itself does not have any intrinsic biological activity, but it can be converted into other compounds that do have therapeutic effects.

Digitoxigenin is a key intermediate in the synthesis of several important drugs, including digoxin and digitoxin. These drugs are used to treat various heart conditions, such as congestive heart failure and atrial fibrillation, by increasing the force of heart contractions and slowing the heart rate.

It is worth noting that digitoxigenin and its derivatives can have toxic effects if used inappropriately or in excessive amounts. Therefore, they should only be administered under the close supervision of a qualified healthcare professional.

Digitoxin is a cardiac glycoside drug that is derived from the foxglove plant (Digitalis lanata). It is used in the treatment of various heart conditions, particularly congestive heart failure and certain types of arrhythmias. Digitoxin works by increasing the force of heart muscle contractions and slowing the heart rate, which helps to improve the efficiency of the heart's pumping action.

Like other cardiac glycosides, digitoxin inhibits the sodium-potassium pump in heart muscle cells, leading to an increase in intracellular calcium levels and a strengthening of heart muscle contractions. However, digitoxin has a longer half-life than other cardiac glycosides such as digoxin, which means that it stays in the body for a longer period of time and may require less frequent dosing.

Digitoxin is available in tablet form and is typically prescribed at a low dose, with regular monitoring of blood levels to ensure safe and effective use. Common side effects of digitoxin include nausea, vomiting, diarrhea, and dizziness. In rare cases, it can cause more serious side effects such as arrhythmias or toxicity, which may require hospitalization and treatment with medications or other interventions.

Cardanolides are a type of steroid compound that are found in certain plants, particularly in the family Apocynaceae. These compounds have a characteristic structure that includes a five-membered lactone ring attached to a steroid nucleus, and they are known for their ability to inhibit the sodium-potassium pump (Na+/K+-ATPase) in animal cells. This property makes cardanolides toxic to many organisms, including humans, and they have been used as heart poisons and insecticides.

One of the most well-known cardanolides is ouabain, which is found in the seeds of several African plants and has been used traditionally as a medicine for various purposes, including as a heart stimulant and a poison for hunting. Other examples of cardanolides include digoxin and digitoxin, which are derived from the foxglove plant (Digitalis purpurea) and are used in modern medicine to treat heart failure and atrial arrhythmias.

It's worth noting that while cardanolides have important medical uses, they can also be highly toxic if ingested or otherwise introduced into the body in large amounts. Therefore, it's essential to use these compounds only under the supervision of a qualified healthcare professional.

Digitalis glycosides are a type of cardiac glycoside that are derived from the foxglove plant (Digitalis purpurea) and related species. These compounds have a steroidal structure with a lactone ring attached to the molecule, which is responsible for their positive inotropic effects on the heart.

The two main digitalis glycosides used clinically are digoxin and digitoxin. They work by inhibiting the sodium-potassium pump in cardiac muscle cells, leading to an increase in intracellular calcium levels and a subsequent enhancement of myocardial contractility. This makes them useful in the treatment of heart failure and atrial arrhythmias such as atrial fibrillation.

However, digitalis glycosides have a narrow therapeutic index, meaning that there is only a small difference between their therapeutic and toxic doses. Therefore, they must be administered with caution and patients should be closely monitored for signs of toxicity such as nausea, vomiting, visual disturbances, and cardiac arrhythmias.

'Digitalis' is a medication that is derived from the foxglove plant (Digitalis purpurea). It contains cardiac glycosides, primarily digoxin and digitoxin, which have positive inotropic effects on the heart muscle, increasing its contractility. Digitalis is primarily used to treat various types of heart failure and atrial arrhythmias. It works by inhibiting the sodium-potassium pump in heart muscle cells, leading to an increase in intracellular calcium and enhanced cardiac muscle contraction.

It's important to note that digitalis has a narrow therapeutic index, meaning that the difference between a therapeutic and toxic dose is small. Therefore, it requires careful monitoring of serum drug levels and clinical response to ensure safe and effective use. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as visual disturbances and cardiac arrhythmias.

Cardenolides are a type of steroid compound that are found in certain plants and animals. These compounds have a characteristic structure that includes a five-membered lactone ring, which is attached to a steroid nucleus. Cardenolides are well known for their toxicity to many organisms, including humans, and they have been used for both medicinal and poisonous purposes.

One of the most famous cardenolides is digitoxin, which is derived from the foxglove plant (Digitalis purpurea). Digitoxin has been used as a medication to treat heart conditions such as congestive heart failure, as it can help to strengthen heart contractions and regulate heart rhythm. However, because of its narrow therapeutic index and potential for toxicity, digitoxin is not commonly used today.

Other cardenolides include ouabain, which is found in the seeds of the African plant Acokanthera ouabaio, and bufadienolides, which are found in the skin and parotid glands of toads. These compounds have also been studied for their potential medicinal uses, but they are not widely used in clinical practice due to their toxicity.

It is important to note that cardenolides can be highly toxic to humans and animals, and exposure to these compounds can cause a range of symptoms including nausea, vomiting, diarrhea, seizures, and even death. As such, it is essential to use caution when handling or coming into contact with plants or animals that contain cardenolides.

Cardiac glycosides are a group of naturally occurring compounds that have a toxic effect on the heart. They are found in certain plants, including foxglove and lily of the valley, as well as in some toads and beetles. The most well-known cardiac glycoside is digoxin, which is derived from the foxglove plant and is used as a medication to treat heart failure and atrial arrhythmias.

Cardiac glycosides work by inhibiting the sodium-potassium pump in heart muscle cells, leading to an increase in intracellular calcium levels. This increases the force of heart contractions, which can be beneficial in treating heart failure. However, if the dose is too high, cardiac glycosides can also cause dangerous arrhythmias and even death.

It's important for healthcare professionals to carefully monitor patients taking cardiac glycosides, as the therapeutic and toxic doses are very close together. Additionally, certain medications and medical conditions can interact with cardiac glycosides and increase the risk of toxicity.

Digitoxigenin, a cardenolide, is the aglycone of digitoxin. Digitoxigenin can be used to prepare actodigin. In Lednicers book ...
Honma, M., & Nakada, M. (2007). Enantioselective total synthesis of (+)-digitoxigenin. Tetrahedron Letters, 48(9), 1541-1544. ... Honma, M & Nakada, M 2007, Enantioselective total synthesis of (+)-digitoxigenin, Tetrahedron Letters, vol. 48, no. 9, pp. ... Enantioselective total synthesis of (+)-digitoxigenin. / Honma, Masahiro; Nakada, Masahisa. In: Tetrahedron Letters, Vol. 48, ... This convergent synthesis would be useful for preparing some new derivatives of digitoxigenin for SAR studies and could be ...
Constituents: Cardenolides based on digitoxigenin Alkaloids such as asparagine & atropurpurine Sterols; euonysterol, ...
Digitoxigenin was used as the internal standard. The analytes were extracted from plasma and urine using solid phase extraction ...
... relationship showed that the cytotoxic activity was reduced by the introduction of a hydroxy group at C-16 of the digitoxigenin ...
Hybridized probe was detected using a polyclonal serum anti-digitoxigenin-AP-conjugated (Boehringer Mannheim) at a final ... either without the TGF-β1 hybridization probe or using the sense probe or omitting the polyclonal serum anti-digitoxigenin-AP- ...
Bioavailability of the bis- and monodigitoxosides of digitoxigenin. Fenster, P. E., MacFarland, R. T., Graves, P. E., Perrier, ... Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects. Graves, P. E., Fenster, P. E., ... Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency. Graves, P. E., Fenster, P. E. ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
Digitoxigenin. Digitoxin. Digoxin. Dihydroxydiphenylsilane. Dikegulac sodium. Dilauroyl peroxide. Dimercury dichloride. ...
Digitoxigenin. Apomorphine. 6-nitroquipazine. 2008−02−14−p03−02−G09. Aligned Time (s). Motion index. 0 5 10 15 20 25 30. 0 20 ...
Figure 2 Digitoxigenin (a cardenolide aglycone). Figure 3 1α, 2α-epoxyscillirosidin (a bufadienolide aglycone) ...
Of these compounds, only digitoxigenin monodigitoxoside and 1-naphthol were found to cause significant inhibition of ... Of these compounds, only digitoxigenin monodigitoxoside and 1-naphthol were found to cause significant inhibition of ... Of these compounds, only digitoxigenin monodigitoxoside and 1-naphthol were found to cause significant inhibition of ... Of these compounds, only digitoxigenin monodigitoxoside and 1-naphthol were found to cause significant inhibition of ...
The leaves contain several glycosides including glycosides of 8 betahydroxy-digitoxigenin. Cardenolide glycosides and ... The leaves contain several glycosides including glycosides of 8 betahydroxy-digitoxigenin. Cardenolide glycosides and ...
O-β-D-digitoxopyranoside and digitoxigenin 3-O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-O-β-D-digitoxopyranoside [16 ...
DIGITOXIGENIN PRESENTS AN EFFECTIVE AND SELECTIVE ANTILEISHMANIAL ACTION AGAINST LEISHMANIA INFANTUM AND IS A POTENTIAL ...
METHODS: Digoxin, a user-designed digitoxigenin-α-L-rhamnoside (D6-MA), and ouabain were tested against various human AML- ...
Ramirez, M.; Del Valle, L.; Sanchez-Mendoza, A.; Tenorio, F.A.; Zarco, G.; Pastelin, G. 2005: Effect of the digitoxigenin ...
Digitoxigenin and ouabain are members of this class of inhibitors, which are known as cardiotonic steroids because of their ...
Herein, we investigated the anticancer effects of digitoxin and its analog, digitoxigenin--L-rhamnoside (D6MA), to establish ...
... including folinerin and digitoxigenin [13]. The cytotoxicity caused by oleandrin was not significantly higher than the Vehicle ...
Digitoxigenin. Bucumolol. Benzoguanamine. Serum Albumin. Andrographis. Nitrobenzene. Phalloidin. Stavudine. Satigrel. ...
Digitoxigenin D4.808.155.160.278.350 D4.808.155.580.130.625.350 Digitoxin D4.808.155.160.278 D4.808.155.580.130.625 Digoxigenin ...
Digitoxigenin D4.808.155.160.278.350 D4.808.155.580.130.625.350 Digitoxin D4.808.155.160.278 D4.808.155.580.130.625 Digoxigenin ...
Digitoxigenin D4.808.155.160.278.350 D4.808.155.580.130.625.350 Digitoxin D4.808.155.160.278 D4.808.155.580.130.625 Digoxigenin ...
Digitoxigenin D4.808.155.160.278.350 D4.808.155.580.130.625.350 Digitoxin D4.808.155.160.278 D4.808.155.580.130.625 Digoxigenin ...
Digitoxigenin D4.808.155.580.130.625.350 D4.210.500.155.580.130.625.350 Digitoxin D4.808.155.580.130.500.336 D4.210.500.155. ...
Digitoxigenin D4.808.155.580.130.625.350 D4.210.500.155.580.130.625.350 Digitoxin D4.808.155.580.130.500.336 D4.210.500.155. ...
... digitoxigenin, beta-eudesmol and favipiravir: comparative study. Biointerface Research in Applied Chemistry 12(4): 5591-5600. ...
... digitoxigenin) ; Derived Quantity: digoxin Ki ; Derived Quantity: ΔΔG (DIG - progesterone) ; Derived Quantity: digitoxigenin Ki ... The optimized binder is selective for DIG over the related steroids digitoxigenin, progesterone and β-oestradiol, and this ... digitoxigenin IC50 measured by fluorescence polarization equilibrium competition ; Experimental Assay: progesterone IC50 ...

No FAQ available that match "digitoxigenin"

No images available that match "digitoxigenin"